Update Variant Browser refresh
Explore redesigned navigation and faster access to curated variant datasets.

SCN5A Variant p.F2004dup

Summary of observed carriers, functional annotations, and structural context for SCN5A p.F2004dup. Data combine curated literature, international cohorts, and gnomAD observations.

Estimated LQT3 penetrance

5%

0/11 effective observations

Estimated BrS1 penetrance

28%

3/11 effective observations

Total carriers

1

1 BrS1 · 0 LQT3 · 0 unaffected

p.F2004dup has not been reported in gnomAD. This residue resides in a Mild_Hotspot region for Brugada syndrome and a Non_Hotspot region for LQT3.

Variant features alone are equivalent to phenotyping 2 individuals for Brugada syndrome and 0 individuals for LQT3.

In silico predictors

Variant-level computational predictors.
PROVEAN PolyPhen-2 BLAST-PSSM REVEL Penetrance Density BrS (%) Penetrance Density LQT3 (%)
NA NA NA None 23 5

PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).

Reported carrier data

Observed carriers by publication or cohort.
Source Year Carriers Unaffected LQT3 BrS1 Other Other Disease
20129283 2010 1 0 1 0
Literature, cohort, and gnomAD 1 0 0 1
Variant features alone 15 13 0 2

Totals may differ from individual publications due to duplicate patients removed during curation.

Functional data

Peak and late/persistent current values are relative to wild-type (100% indicates no change). V1/2 activation and inactivation denote the membrane potentials (mV) at which half-maximal current is achieved.

Published electrophysiology measurements.
PubMed ID Year Cell Type Peak Current (% WT) V1/2 Activation (mV) V1/2 Inactivation (mV) Late/Persistent Current (% WT)
20129283 2010

Nearby variants

Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.

Previously observed variants near p.F2004dup.
Neighbour residue Distance (Å) Observed variants
1989 15
1990 14 V1990L,
1991 14 R1991Q, R1991W,
1992 13 G1992A,
1993 13
1994 12
1995 11 Y1995X,
1996 11 S1996N, S1996R,
1997 10 H1997R,
1998 9
1999 8
2000 8 D2000Y,
2001 7
2002 5 A2002T,
2003 4 D2003N,
2004 0 F2004V, F2004L, p.F2004dup, F2004I,
2005 4 P2005L, P2005S, P2005A,
2006 5 P2006T, p.Pro2006del, P2006A, p.P2006LfsX32,
2007 7 p.S2007FfsX7,
2008 8 P2008L,
2009 8 D2009E,
2010 9 R2010G,
2011 10
2012 11 R2012H, R2012C
2013 11
2014 12
2015 13
2016 13 V2016M, V2016L,